Takeshita T, Kaminaga T, Kikuchi Y, Furui S
Department of Radiology, Teikyo University School of Medicine, Tokyo, Japan.
Clin Nucl Med. 2000 Jun;25(6):495-6. doi: 10.1097/00003072-200006000-00030.
The authors report a case of multiple myeloma with increased accumulation of Tc-99m hexamethylpropylene amine oxime (HMPAO) on brain SPECT. Tc-99m HMPAO is a lipophilic compound that freely passes through the intact blood-brain barrier and cell membrane and is rapidly converted to a hydrophilic form by glutathione and then retained in the neuron for several hours. In general, Tc-99m HMPAO shows decreased accumulation in brain tumors. However, some reports of increased accumulation in brain tumors, such as meningioma, glioblastoma multiforme, high-grade astrocytoma, pituitary adenoma, and multiple myeloma, have been published. The Tc-99m HMPAO uptake in these tumors has been attributed to tumor blood flow or glutathione contents within the tumor. With regard to uptake to Tc-99m HMPAO in multiple myeloma, the tumor size is considered to be an additional factor.
作者报告了一例多发性骨髓瘤患者,其脑单光子发射计算机断层扫描(SPECT)上锝-99m六甲基丙烯胺肟(HMPAO)的蓄积增加。锝-99m HMPAO是一种亲脂性化合物,可自由通过完整的血脑屏障和细胞膜,并迅速被谷胱甘肽转化为亲水性形式,然后在神经元中保留数小时。一般来说,锝-99m HMPAO在脑肿瘤中的蓄积减少。然而,已经发表了一些关于脑肿瘤中蓄积增加的报道,如脑膜瘤、多形性胶质母细胞瘤、高级别星形细胞瘤、垂体腺瘤和多发性骨髓瘤。这些肿瘤中锝-99m HMPAO的摄取归因于肿瘤血流或肿瘤内的谷胱甘肽含量。关于多发性骨髓瘤中锝-99m HMPAO的摄取,肿瘤大小被认为是一个额外的因素。